Spinraza (nusinersen) billing

Spinraza (nusinersen) is a medication that was approved in December 2016 by the U.S. FDA for the treatment of all forms of SMA. HCPCS code J2326 - Inj, nusinersen, 0.1mg should be used to report Spinraza. Spinraza is administered by intrathecal injection and should be billed using CPT code 96450 - Chemotherapy administration, into CNS (e.g., intrathecal), requiring and including spinal puncture.

Reviewed 9/19/2024